Literature DB >> 6785298

Obesity and its role in polycystic ovary syndrome.

S R Plymate, B L Fariss, M L Bassett, L Matej.   

Abstract

To examine the mechanism by which obesity influences ovulation, 55 patients with oligo- or anovulation were studied. Parameters measured in serum were sex steroid-binding globulin (SSBG), testosterone (T), PRL, LH, FSH, and estradiol (E2). The women were divided into 2 groups: an obese group (group 1), greater than 145% of ideal body weight, and a normal weight group, less than 120% ideal body weight. SSBG was measured by saturation analysis T, LH, FSH, PRL, and E2 were measured by RIA. SSBG group 1 levels were 7.14 ng dihydrotestosterone bound/ml compared to 14.7 ng dihydrotestosterone bound/ml in group 2 (P less than 0.05). There were no significant differences in FSH, T, or E2. The correlation of body weight vs. SSBG in all patients was r = -0.62. In these 2 groups, the SSBG was significantly lower in the obese patients compared to that in the normal weight patients, independent of T or E2 levels. SSBG correlated negatively with body weight, suggesting that obesity has an influence on SSBG levels independent of hormonal status. When SSBG is lowered, there may be an increase in free T which, by inhibiting follicular maturation, may begin the sequence of events seen in polycystic ovary syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785298     DOI: 10.1210/jcem-52-6-1246

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

Review 2.  How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

Authors:  C Cortet-Rudelli; D Dewailly
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

3.  Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.

Authors:  R Paradisi; S Venturoli; R Pasquali; M Capelli; E Porcu; R Fabbri; C Flamigni
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

4.  Sex hormones in obese premenopausal women and their relationships to body fat mass and distribution, B cell function and diet composition.

Authors:  R Pasquali; D Antenucci; N Melchionda; R Fabbri; S Venturoli; D Patrono; M Capelli
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

Review 5.  Insulin and hyperandrogenism in women with polycystic ovary syndrome.

Authors:  Catherine G Baptiste; Marie-Claude Battista; Andréanne Trottier; Jean-Patrice Baillargeon
Journal:  J Steroid Biochem Mol Biol       Date:  2009-12-28       Impact factor: 4.292

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.